Illumina Feb 2, 2026 PacBio sells short-read DNA sequencing assets to Illumina for $48.1m - Investing.com
Illumina Feb 2, 2026 Pacific Biosciences of California Signs Asset Purchase Agreement With Illumina Cambridge - TradingView
Thermo Fisher Feb 2, 2026 Thermo Fisher Scientific’s venture arm brings Massey onboard - Global Venturing
10x Genomics Blog Feb 2, 2026 Foundations Investment Advisors LLC Takes Position in 10x Genomics $TXG - MarketBeat
Illumina Feb 2, 2026 PacBio Completes Sale of Short-Read Sequencing Assets to Illumina for $48.1 Million - Quiver Quantitative
PLoS Biology Feb 2, 2026 Epimutations driven by RNAi or heterochromatin evoke transient antimicrobial drug resistance in pathogenic <i>Mucor</i> fungi
PLoS Biology Feb 2, 2026 Grik2b and Grik2c kainate receptors regulate oviposition in <i>Bactrocera dorsalis</i>
PLoS Biology Feb 2, 2026 The CspC:CspA heterodimer transduces germinant and co-germinant signals during <i>Clostridioides difficile</i> spore germination
PLoS Biology Feb 2, 2026 DNA damage induced by HIV-1 Vpr triggers epigenetic remodeling and transcriptional programs to enhance virus transcription and latency reactivation
PLoS Biology Feb 2, 2026 Recurrent mutations in the stress regulator Cap1 reveal a trade-off between azole resistance and oxidative stress response in <i>Candida albicans</i>
Roche Media Feb 2, 2026 Roche continues RNA return with $1.7B deal for Sanegene drug - Fierce Biotech